Skip to main content
. 2022 Oct 19;13:6187. doi: 10.1038/s41467-022-33744-5

Fig. 3. Osteoarthritis development in chondrocyte-specific homozygous and heterozygous Runx2-knockout mice.

Fig. 3

a Safranin-O staining and Osteoarthritis Research Society International (OARSI) scores of mouse knee joints of Runx2fl/+ (R2-Hetero Cntl), Col2a1-CreERT2; Runx2fl/+ (R2-Hetero cKO), Runx2fl/fl (R2-Homo Cntl), and Col2a1-CreERT2; Runx2fl/fl (R2-Homo cKO) mice 12 weeks after surgery to destabilize the medial meniscus (DMM) or 8 weeks after resection of the medial meniscus and medial collateral ligament (medial model). Tamoxifen induction was performed at 15 weeks in the DMM group and 7 weeks in the medial model group. Experimental groups consisted of n = 13, 14, 20, and 12 in the DMM model, respectively, and n = 16 per genotype in the medial model. Scale bars, 200 μm. Safranin-O staining and immunohistochemistry of Runx2, Sox9, Col2a1, and Mmp13 in sham (b) and surgical (c) joints of the medial model group. n = 6 biologically independent experiments. Scale bars, 100 μm. Data are expressed as dot plots and mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, #P < 0.0001; ns, not significant; one-way ANOVA test with Turkey’s post hoc test.